BCL2 and acute myeloid leukemia: Given that Bcl-2 has been directly implicated in survival and resistance of AML and MM cells from several therapies30,31, we performed cytotoxicity assays in the presence of stroma with or without the addition of a Bcl-2 inhibitor HA14-1.